North Carolina Biotech Newsletter
|
April 2012 |
||||||||||||||
|
| |
| |
|
| |
|
| |
|
||||||||
TOP NEWS STORIES from the North Carolina Biotechnology Center
Medical device firm moving to N.C. “We are excited to be moving our North American headquarters to North Carolina,” said Chip Neff, president of Aerocrine. “The state’s leading position in respiratory disease research and commercialization of cutting-edge products was critical in our decision to locate our business in North Carolina.” Life sciences survival guide from Chris Viehbacher Sanofi CEO Christopher Viehbacher, the opening speaker for the 2012 CED Life Science Conference, laid the groundwork with a call for innovation and collaboration. Biotech Center/NCBIO stage successful partnering event The Biotech Center and the North Carolina Biosciences Organization (NCBIO) have staged partnering sessions for years to let entrepreneurs, investors and blue-chip life-science giants exchange dance cards and explore possible deals. This was the biggest year yet, with 396 registrants and over 150 life science companies participating. Wake Forest innovation center opens in former tobacco facility The 242,000-square-foot, $100 million-plus renovation of the former R.J. Reynolds Tobacco Co. facility is the newest major symbol of North Carolina’s transition from its earlier reliance on a tobacco economy to the state’s 21st Century leadership in the life sciences. Biotech Place marks the largest capital investment for a construction project in the history of downtown Winston-Salem.
|
||||||||||||||
